Anti Cancer Medicine

Product Details:

Indication

ZEJULA is indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.

Important Safety Information

Myelodysplastic Syndrome/Acute Myeloid Leukemia (MDS/AML), including some fatal cases, was reported in 1.4% of patients receiving ZEJULA vs 1.1% of patients receiving placebo in Trial 1 (NOVA), and 0.9% of patients treated with ZEJULA in all clinical studies. The duration of ZEJULA treatment in patients prior to developing MDS/AML varied from <1 month to 2 years. All patients had received prior chemotherapy with platinum and some had also received other DNA damaging agents and radiotherapy. Discontinue ZEJULA if MDS/AML is confirmed.

Hematologic adverse reactions (thrombocytopenia, anemia and neutropenia) have been reported in patients receiving ZEJULA. Grade ≥3 thrombocytopenia, anemia and neutropenia were reported in 29%, 25%, and 20% of patients receiving ZEJULA, respectively. Discontinuation due to thrombocytopenia, anemia, and neutropenia occurred, in 3%, 1%, and 2% of patients, respectively. Do not start ZEJULA until patients have recovered from hematological toxicity caused by prior chemotherapy (≤ Grade 1). Monitor complete blood counts weekly for the first month, monthly for the next 11 months of treatment, and periodically thereafter. If hematological toxicities do not resolve within 28 days following interruption, discontinue ZEJULA, and refer the patient to a hematologist for further investigations.

Hypertension and hypertensive crisis have been reported in patients receiving ZEJULA. Grade 3-4 hypertension occurred in 9% of patients receiving ZEJULA vs 2% of patients receiving placebo in Trial 1, with discontinuation occurring in <1% of patients. Monitor blood pressure and heart rate monthly for the first year and periodically thereafter during treatment with ZEJULA. Closely monitor patients with cardiovascular disorders, especially coronary insufficiency, cardiac arrhythmias, and hypertension. Manage hypertension with antihypertensive medications and adjustment of the ZEJULA dose, if necessary.

Based on its mechanism of action, ZEJULA can cause fetal harm. Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception during treatment and for 6 months after receiving their final dose. Because of the potential for serious adverse reactions from ZEJULA in breastfed infants, advise lactating women to not breastfeed during treatment with ZEJULA and for 1 month after receiving the final dose.

In clinical studies, the most common adverse reactions (Grades 1-4) in ≥10% of patients included: thrombocytopenia (61%), anemia (50%), neutropenia (30%), leukopenia (17%), palpitations (10%), nausea (74%), constipation (40%), vomiting (34%), abdominal pain/distention (33%), mucositis/stomatitis (20%), diarrhea (20%), dyspepsia (18%), dry mouth (10%), fatigue/asthenia (57%), decreased appetite (25%), urinary tract infection (13%), aspartate aminotransferase (AST)/alanine aminotransferase (ALT) elevation (10%), myalgia (19%), back pain (18%), arthralgia (13%), headache (26%), dizziness (18%), dysgeusia (10%), insomnia (27%), anxiety (11%), nasopharyngitis (23%), dyspnea (20%), cough (16%), rash (21%) and hypertension (20%).

Common lab abnormalities (Grades 1-4) in ≥25% of patients included: decrease in hemoglobin (85%), decrease in platelet count (72%), decrease in white blood cell count (66%), decrease in absolute neutrophil count (53%), increase in AST (36%) and increase in ALT (28%).

 

Product Details:

Lenalid 25 Capsule is used in the treatment of myelodysplastic syndrome, a group of blood disorders characterized by immature cells. It is also used in a combination with dexamethasone for the treatment of multiple myeloma, a type of blood cancer. This medicine is not recommended for use in pregnant women as well as in patients less than 18 years of age.

Additional Information:

• Production Capacity: 10000

Product Details:

Lenvatinib is used to treat progressive, differentiated thyroid cancer that can no longer be treated with radioactive iodine and has already spread to different parts of the body. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Lenvatinib is an antineoplastic (cancer) medicine.

Product Details:

Kisqali

Ribociclib

RIBOCICLIB is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat breast cancer. Compare kinase inhibitors.

Additional Information:

• Packaging Details: AS PER AS DEMAND

Product Details:

Kryxana 200 mg Tablet is an anticancer medicine used in combination with other medicines to treat certain types of breast cancer. Close monitoring of blood cell count is recommended during treatment with this medicine. This medicine is not recommended for use in patients below 18 years of age.

Additional Information:

• Packaging Details: AS PER AS DEMAND

Product Details:

Ocrelizumab (trade name Ocrevus) is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes and hence is an immunosuppressive drug. Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds.

It was approved by the FDA in March 2017 as a treatment for multiple sclerosis, and the first FDA approved drug for the primary progressive form of MS; it was discovered and developed and is marketed by Hoffmann–La Roche's subsidiary Genentech under the trade name Ocrevus.

Additional Information:

• Packaging Details: AS PER AS DEMAND

Product Details:

XALKORI is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. It is not known if XALKORI is safe and effective in children.

Additional Information:

• Packaging Details: AS PER AS DEMAND

Product Details:

An article in The New England Journal of Medicine, published January 2007, showed that, compared with placebo, treatment with sorafenib prolongs progression-free survival in patients with advanced clear cell renal cell carcinoma in whom previous therapy has failed. The median progression-free survival was 5.5 months in the sorafenib group and 2.8 months in the placebo group (hazard ratio for disease progression in the sorafenib group, 0.44; 95% confidence interval [CI], 0.35 to 0.55; P<0.01). A few reports described patients with stage IV renal cell carcinomas, metastasized to the brain, that were successfully treated with a multimodal approach including neurosurgical, radiation, and sorafenib.

Product Details:

VENCLEXTA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, who have received at least one prior therapy.

Additional Information:

• Delivery Time: 3 DAYS
• Packaging Details: AS PER DEMAND

Product Details:

ERIVEDGE is indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation.

Additional Information:

• Delivery Time: 3 days
• Packaging Details: AS PER DEMAND

Product Details:

we are engage in offering Sorafenat Tablets to our esteemed buyers across the globe. We procure the tablets from trust worthy manufactures who formulate them in adherence to sets international medical standards

Product Details:

Synvisc-One^® (hylan G-F 20) is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. Important Safety Information for Synvisc-One Before trying Synvisc-One, tell your doctor if you have had an allergic reaction, such as swelling of the face, tongue or throat, respiratory difficulty, rash, itching or hives to SYNVISC or any hyaluronan-based products. Allergic reactions, some which can be potentially severe, have been reported during the use of Synvisc-One. Should not be used in patients with an infected knee joint, skin disease or infection around the area where the injection will be given, and should be used with caution when there is swelling of the legs due to problems with venous stasis or lymphatic drainage. Synvisc-One is only for injection into the knee, performed by a doctor or other qualified health care professional. Synvisc-One has not been tested to show pain relief in joints other than the knee. Tell your doctor if you are allergic to products from birds – such as feathers, eggs or poultry – or if your leg is swollen or infected. Synvisc-One has not been tested in children (≤21years old), pregnant women or women who are nursing. You should tell your doctor if you think you are pregnant or if you are nursing a child. Talk to your doctor before resuming strenuous weight-bearing activities after treatment

Product Details:

Mekinist or Mekinist Generic, Trametinib is used for the treatment of metastatic melanoma that refers to the IV stage of skin cancer that is caused owing to a defect in a gene known as BRAF. To take Mekinist or generic Mekinist, Trametinib, the cancer must be as indicated by the FDA approved test, BRAF Positive.

Mekinist Dosing, Strength and Administration

Adults can take Mekinist or generic Mekinist, Trametinib 2 mg orally every day as a single agent. With combination therapy, Mekinist is taken orally once daily 2mg with Dabrafenib twice a day 150 mg.

Product Details:

LONSURF® (trifluridine and tipiracil), a prescription medicine, is for people:

• Whose colon or rectal cancer has spread to other parts of the body (this is called “metastatic”)
• Who have previously been treated with or cannot receive certain chemotherapy medicines
• Who now may need another option

Product Details:

LYNPARZA is a prescription medicine used to treat women with advanced ovarian cancer who have received previous treatment with 3 or more prior chemotherapy medicines or a combination of chemotherapy medicines for their cancer, and have a certain type of abnormal inherited BRCA gene.

Your healthcare provider will perform a test to make sure that LYNPARZA is right for you.

Product Details:

6-mercaptopurine is indicated for the treatment of acute leukaemia. It may be utilised in remission induction and it is particularly indicated for maintenance therapy in:

– acute lymphoblastic leukaemia (ALL);

– acute myelogenous leukaemia (AML).

Mercaptopurine may be used in the treatment of chronic granulocytic leukaemia.

PROVENGE is the only personalized immunotherapy treatment that is clinically proven to help extend life in certain men with advanced prostate cancer.

PROVENGE is an immunotherapy that takes your own immune cells and reprograms them to attack your advanced prostate cancer. This process delivers a treatment designed just for you.

Product Details:

Human Albumin 20% /100ml

Product Details:

Maviret is used to treat hepatitis C in adults with genotype 1, 2, 3, 4, 5 or 6 (Pan-Genotype).

 

Marivet is a two-drug combination administered as 3 tablets once a day containing glecaprevir and pibrentasvir. There is no need for ribavirin.

 

The treatment duration is 8, 12 or 16 weeks depending on past treatment experience.

Additional Information:

• Delivery Time: 3 DAYS
• Packaging Details: AS PER DEMAND

Product Details:

Crizotinib 200 mg Capsule is a new drug being used to treat lung cancer. It is also called Xalkori. It is a type of drug called a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that act as chemical messengers in cells. Tyrosine kinase inhibitors are drugs that block or slow down these proteins.
How does it work:
Crizotinib blocks a protein called ALK or anaplastic lymphoma kinase. Some lung cancers

Additional Information:

• Packaging Details: AS PER AS DEMAND

Product Details:

• Breast Cancer: Treatment (in combination with exemestane) of advanced breast cancer in postmenopausal women following failure of letrozole or anastrozole therapy.
• Neuroendocrine Tumors (NET): Treatment of certain advanced neuroendocrine tumors of pancreatic, gastrointestinal, or lung origin.
• Renal Cell Carcinoma (RCC): Treatment of advanced renal cell carcinoma after failure of treatment with sunitinib or sorafenib.

Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful. Everolimus has also been used in heart, liver or kidney transplantation, Waldenstrom macroglobulinemia, and certain carcinoid tumors.

*This list is not all-inclusive. It is important to discuss the decision to start or stop any medication, including everolimus, closely with your physician.

Product Details:

Rituximab is used to treat certain types of cancer (such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia). It works by slowing or stopping the growth of cancer cells.

Rituximab is used to treat rheumatoid arthritis and can decrease joint pain and swelling. It is also used to treat certain types of blood vessel disease (such as granulomatosis with polyangiitis, microscopic polyangiitis) and can decrease the swelling of the blood vessels. Rituximab is also used to treat a certain skin condition (pemphigus vulgaris). It helps to reduce the number of skin lesions.

Additional Information:

• Delivery Time: 3 DAYS
• Packaging Details: AS PER DEMAND

Product Details:

Tasigna (nilotinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Tasigna is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML) in adults and children who are at least 1 year old.

Product Details:

This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells

Additional Information:

• Packaging Details: AS PER AS DEMAND

Product Details:

Uses:-Arimidex Tablets is used to treat breast cancer in women who have gone through (menopause). Arimidex Tabletsworks by lowering estrogen hormone levels to help shrink tumors and slow their growth.

Side Effects:- Hot flushes and sweats, Risk of osteoporosis,Skin rashes, Feeling sick (nausea) and being sick (vomiting),Headaches, Joint pains/muscular stiffness

Product Details:

Targretin® (bexarotene) is a member of a subclass of retinoids that selectively activate retinoid X receptors (RXRs). These retinoid receptors have biologic activity distinct from that of retinoic acid receptors (RARs). Each soft gelatin capsule for oral administration contains 75 mg of bexarotene.

Product Details:

Aricept 10mg tablet is used to treat mild to moderate dementia caused by Alzheimer''s disease, Parkinson''s disease. It increases the levels of a chemical messenger involved in the transmission of nerve signals.

Additional Information:

• Packaging Details: AS PER AS DEMAND

Product Details:

Oxitan - Oxaliplatin Injection 50 mg & 100 mg

We sell Dacotin from Dabur at best prices and we also have Oxaliplatin Generic Injection at very good discounted prices in Gurgaon or Delhi NCR or other Indian Regions as well as outside India to any other Countries of the world.

We also ship this medicine to any country of the world as per the buyer's requirements.
Dacotin contains Oxaliplatin 50mg and 100mg Injection form and it used in treatment of pregnant women may be acceptable despite the risk
We take guarantee of quality and delivery anywhere in the world as per the buyers requirements

Clogen 10 MG Tablet is a broad spectrum antifungal medicine used to treat skin infections such as athlete's foot, jock itch and ringworm. It also relieves symptoms such as burning, itching, cracking of the skin and discomfort caused by these infections.

Additional Information:

• Minimum Order Quantity: 1 Tablet

Product Details:

Stivarga (regorafenib) is a cancer medication that interferes with the growth and spread of cancer cells in the body.

Stivarga is used to treat colorectal cancer. It is also used to treat a rare type of tumor that can affect the esophagus, stomach, or intestines.

Stivarga is usually given after other cancer medications have been tried without success.

Product Details:

Aprepitant is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor.

Product Details:

GILOTRIF is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC):

That has certain types of abnormal epidermal growth factor receptor (EGFR) genes. Your doctor will perform a test to check for certain types of abnormal EGFR genes, and make sure that GILOTRIF is right for you. GILOTRIF may be used when you have not had previous treatment for cancer that has spread to other parts of the body. It is not known if GILOTRIF is safe and effective in treating lung cancer with other abnormal EGFR genes.

Jakafi is a prescription medicine used to treat people with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.

Jakafi is also used to treat certain types of myelofibrosis.

Panimun Bioral 100 mg Capsule is an immuno-suppressant which is used in organ transplant patients, Rheumatoid Arthritis and Psoriasis. It should be used under the supervision of a qualified physician. Close monitoring of kidney function is necessary while receiving this medicine.

Additional Information:

• Minimum Order Quantity: 1 Bottle

Product Details: